未登录

Y

Yong Soo Kwon

nhis ilsan hospital

H指数:41

被引数:5,518

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Depressive episode and treatment outcomes in elderly individuals with tuberculosis: A prospective cohort study in Korea

结核病老年患者的抑郁发作与治疗结局：韩国一项前瞻性队列研究

IF2.6

2025-11-060

PRE

Quercetin-3-Methyl Ether Induces Early Apoptosis to Overcome HRV1B Immune Evasion, Suppress Viral Replication, and Mitigate Inflammatory Pathogenesis

BIOMOLECULES & THERAPEUTICS

IF3.2

2025-02-210

PRE

Better Chemotherapeutic Response of Small Cell Lung Cancer in Never Smokers than in Smokers

从未吸烟者的小细胞肺癌化疗反应优于吸烟者

TUBERCULOSIS AND RESPIRATORY DISEASES

IF3

2025-02-110

OA

Antioxidant Potential and In Vitro Antidiabetic Activity of Paeonia japonica (Makino) Miyabe & Takeda Extract and Its Isolated Compounds

IF3.4

2024-11-160

OA

Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort

非结核分枝杆菌肺病抗生素治疗后健康相关生活质量的改善: NTM-韩国队列的初步分析

CLINICAL INFECTIOUS DISEASES

IF7.3

2024-04-024

PRE

Compliance with new drug use and the effect of discrepant drug susceptibility testing on MDR/RR-TB treatment

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

IF3.1

2024-02-011

PRE

Antiviral Mechanisms of Saucerneol from Saururus chinensis against Enterovirus A71, Coxsackievirus A16, and Coxsackievirus B3: Role of Mitochondrial ROS and the STING/TKB-1/IRF3 Pathway

IF3.5

2023-12-211

OAAI

Antioxidant and Antiproliferative Activities of Eclipta prostrata (L.) L. Extract and Isolated Compounds

Eclipta prostrata (L.) L的抗氧化和抗增殖活性。提取物和分离化合物

IF4.6

2023-10-305

OAAI

Effect of Bioreactor Cultures on the Proliferation and Biological Activity of Protocorm-like Bodies of Dendrobium loddigesii

IF3.4

2023-07-210

OA

Caffeic acid methyl ester inhibits mast cell activation through the suppresion of MAPKs and NF-κB signaling in RBL-2H3 cells

IF3.6

2023-06-015

OAAI

Treatment outcomes of multidrug-resistant TB with selective use of new drugs

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

IF3.1

2023-01-013

PRE

Impacts of Asthma in Patients With Bronchiectasis: Findings From the KMBARC Registry

哮喘对支气管扩张患者的影响: 来自KMBARC注册表的发现

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH

IF4.3

2023-01-014

OAAI

Trends and an Online Survey on the Use of Rigid Bronchoscopy in Korea

JOURNAL OF KOREAN MEDICAL SCIENCE

IF2.3

2023-01-015

OAAI

Impact of revised definitions for extensively drug-resistant TB on disease classification

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

IF3.1

2021-09-012

PRE

α-Glucosidic hydroquinone derivatives from Viburnum erosum

IF3.4

2021-07-012

PRE

Analysis of Non-TB Mycobacterial Lung Disease in Patients With Primary Sjogren's Syndrome at a Referral Center

IF8.6

2021-06-013

OAAI

Impact of Bronchiectasis on Incident Nontuberculous Mycobacterial Pulmonary Disease A 10-Year National Cohort Study

IF8.6

2021-05-0120

OAAI

Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South Korea

EUROPEAN RESPIRATORY JOURNAL

IF21

2020-10-2212

OAAI

Flavonoids from Scutellaria baicalensis inhibit senescence-associated secretory phenotype production by interrupting IκBζ/C/EBPβ pathway: Inhibition of age-related inflammation

IF8.3

2020-09-0110

PREAI

Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation

JOURNAL OF KOREAN MEDICAL SCIENCE

IF2.3

2020-01-019

OAAI